BACKGROUND: Acetyl Coenzyme A carboxylase β (ACACB) is the rate-limiting enzyme in fatty acid oxidation, and continuous fatty acid oxidation in Acacb knock-out mice increases insulin sensitivity. Systematic human studies have not been performed to evaluate whether ACACB variants regulate gene expression and insulin sensitivity in skeletal muscle and adipose tissues. We sought to determine whether ACACB transcribed variants were associated with ACACB gene expression and insulin sensitivity in non-diabetic African American (AA) and European American (EA) adults. METHODS: ACACB transcribed single nucleotide polymorphisms (SNPs) were genotyped in 105 EAs and 46 AAs whose body mass index (BMI), lipid profiles and ACACB gene expression in subcutaneous adipose and skeletal muscle had been measured. Allelic expression imbalance (AEI) was assessed in lymphoblast cell lines from heterozygous subjects in an additional EA sample (n = 95). Selected SNPs were further examined for association with insulin sensitivity in a cohort of 417 EAs and 153 AAs. RESULTS: ACACB transcribed SNP rs2075260 (A/G) was associated with adipose ACACB messenger RNA expression in EAs and AAs (p = 3.8×10(-5), dominant model in meta-analysis, Stouffer method), with the (A) allele representing lower gene expression in adipose and higher insulin sensitivity in EAs (p = 0.04). In EAs, adipose ACACB expression was negatively associated with age and sex-adjusted BMI (r = -0.35, p = 0.0002). CONCLUSIONS: Common variants within the ACACB locus appear to regulate adipose gene expression in humans. Body fat (represented by BMI) may further regulate adipose ACACB gene expression in the EA population.
BACKGROUND: Acetyl Coenzyme A carboxylase β (ACACB) is the rate-limiting enzyme in fatty acid oxidation, and continuous fatty acid oxidation in Acacb knock-out mice increases insulin sensitivity. Systematic human studies have not been performed to evaluate whether ACACB variants regulate gene expression and insulin sensitivity in skeletal muscle and adipose tissues. We sought to determine whether ACACB transcribed variants were associated with ACACB gene expression and insulin sensitivity in non-diabetic African American (AA) and European American (EA) adults. METHODS:ACACB transcribed single nucleotide polymorphisms (SNPs) were genotyped in 105 EAs and 46 AAs whose body mass index (BMI), lipid profiles and ACACB gene expression in subcutaneous adipose and skeletal muscle had been measured. Allelic expression imbalance (AEI) was assessed in lymphoblast cell lines from heterozygous subjects in an additional EA sample (n = 95). Selected SNPs were further examined for association with insulin sensitivity in a cohort of 417 EAs and 153 AAs. RESULTS:ACACB transcribed SNP rs2075260 (A/G) was associated with adiposeACACB messenger RNA expression in EAs and AAs (p = 3.8×10(-5), dominant model in meta-analysis, Stouffer method), with the (A) allele representing lower gene expression in adipose and higher insulin sensitivity in EAs (p = 0.04). In EAs, adiposeACACB expression was negatively associated with age and sex-adjusted BMI (r = -0.35, p = 0.0002). CONCLUSIONS: Common variants within the ACACB locus appear to regulate adipose gene expression in humans. Body fat (represented by BMI) may further regulate adiposeACACB gene expression in the EA population.
Authors: Amy Hansen; Stephen Henderson; Dimitrios Lagos; Leonid Nikitenko; Eve Coulter; Sinead Roberts; Fiona Gratrix; Karlie Plaisance; Rolf Renne; Mark Bower; Paul Kellam; Chris Boshoff Journal: Genes Dev Date: 2010-01-15 Impact factor: 11.361
Authors: David B Savage; Cheol Soo Choi; Varman T Samuel; Zhen-Xiang Liu; Dongyan Zhang; Amy Wang; Xian-Man Zhang; Gary W Cline; Xing Xian Yu; John G Geisler; Sanjay Bhanot; Brett P Monia; Gerald I Shulman Journal: J Clin Invest Date: 2006-02-16 Impact factor: 14.808
Authors: Mete Civelek; Raffi Hagopian; Calvin Pan; Nam Che; Wen-pin Yang; Paul S Kayne; Niyas K Saleem; Henna Cederberg; Johanna Kuusisto; Peter S Gargalovic; Todd G Kirchgessner; Markku Laakso; Aldons J Lusis Journal: Hum Mol Genet Date: 2013-04-04 Impact factor: 6.150
Authors: Renato Assis Machado; Hercílio Martelli-Junior; Silvia Regina de Almeida Reis; Erika Calvano Küchler; Rafaela Scariot; Lucimara Teixeira das Neves; Ricardo D Coletta Journal: Front Cell Dev Biol Date: 2021-07-08
Authors: Lijun Ma; Mariana Murea; James A Snipes; Alejandra Marinelarena; Jacqueline Krüger; Pamela J Hicks; Kurt A Langberg; Meredith A Bostrom; Jessica N Cooke; Daisuke Suzuki; Tetsuya Babazono; Takashi Uzu; Sydney C W Tang; Ashis K Mondal; Neeraj K Sharma; Sayuko Kobes; Peter A Antinozzi; Matthew Davis; Swapan K Das; Neda Rasouli; Philip A Kern; Nathan J Shores; Lawrence L Rudel; Matthias Blüher; Michael Stumvoll; Donald W Bowden; Shiro Maeda; John S Parks; Peter Kovacs; Robert L Hanson; Leslie J Baier; Steven C Elbein; Barry I Freedman Journal: PLoS One Date: 2013-02-27 Impact factor: 3.240